December 16, 2019, Foster City, CA, Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a biopharmaceutical company focused on the development and commercialization of novel therapies for debilitating liver diseases, today announced the...
Spherics
Spherics focused on applying its oral drug delivery platform to develop products with improved therapeutic profiles.
Spherics
Mansfield, MA
